Skip to content
As you might know, The Valens Company Inc. (TSE:VLNS) recently reported its quarterly numbers. Revenues were in line......
Clay Siegall has been the CEO of Seattle Genetics, Inc. (NASDAQ:SGEN) since 2002, and this article will examine the......
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to......
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep......
K12 Inc.'s (NYSE:LRN) price-to-earnings (or "P/E") ratio of 80x might make it look like a strong sell right now......
The European Union is reportedly in talks to make advance purchase deals of potential COVID-19 vaccines with drugmakers Moderna (MRNA), Sanofi (SNY) and Johnson & Johnson (JNJ) as well as biotech firms BioNtech (BNTX) and CureVac.The most advanced talks appear to be those with Johnson & Johnson and Sanofi because the EU is already discussing details on the number of doses needed, Reuters reported. With U.S. giant Johnson & Johnson, the EU is negotiating a supply of 200 million doses of its potential vaccine, the Reuters report said, adding that additional supplies may also be available.“We are in talks with several companies on possible COVID-19 vaccines,” a spokesman for the Commission told Reuters on Friday, declining to comment on specific firms as negotiations were confidential.In the second half of next year, the EU is also planning to secure 300 million doses of the potential vaccine developed by France’s Sanofi in cooperation...
Healthcare costs, Social Security and lifestyle choices should be considered before you act on an early retirement offer....
